Skip to main content
!
Phase III+: The University is open for expanded research operations; only authorized personnel will be admitted on campus. More info here.

The immune system mounts a lasting defense after recovery from COVID-19

The study participants continued to improve their antibodies months after initial infection, potentially due to exposure to remnants of the virus hidden in the gut.

The blood may hold clues to some of COVID-19’s most mysterious symptoms

COVID-19 causes a host of diverse complications, from lung inflammation to blood clots, heart failure, and brain fog. A team of scientists believes these attributes may have a single culprit—and that findings from research on Alzheimer’s disease might give them a leg up in finding it.

Rockefeller begins testing of new COVID-19 antibody drug in people

Patients in the clinical trial will receive two highly potent antibodies against SARS-CoV-2 discovered at the university. Designed to prevent people with early COVID-19 from developing severe disease, the treatment is urgently needed as hospitals continue to be inundated by repeated surges of infection, and mass vaccinations are still months away.

What Darwin never guessed 

Scientists have found that evolution isn’t always a one-way street toward specialization.

Scientists capture the moving parts of the portal to the cell’s nucleus

The proteins of the nuclear pore complex flip-flop rapidly between two orientations as they let cargo through.

Study of 50,000 people finds brown fat may protect against many diseases

People with brown fat tissue tend to burn calories more quickly, but do they also enjoy better health? Now the largest study of its kind shows that brown fat is indeed linked to reduced risk of heart disease, type 2 diabetes, and several other conditions.

Llamas immune to coronavirus, what zebrafish are thinking, and other memorable science stories of 2020 

This year's scientific endeavors included multiple attacks on SARS-CoV-2—and a lot more. Here are the most memorable science stories to come out of Rockefeller labs, from cracking the code behind specific skin cancer subtypes to understanding what goes on inside a fish brain.

As COVID-19 vaccines emerge, the search for antiviral drugs continues

Scientists are digging through drug libraries of 430,000 compounds, in pursuit of an antiviral drug that can stop the novel coronavirus in its tracks.

A mediocre mutator 

Scientists developed a method to safely examine the ability of SARS-CoV-2 to escape future drugs or vaccines by mutating. Their initial results are reassuring.

Royalty Pharma and Pablo and Almudena Legorreta Support Development of Antibody-Based COVID-19 Therapy at The Rockefeller University

Royalty Pharma and The Rockefeller University announced generous gifts totaling $5,760,000 from Royalty Pharma and Pablo and Almudena Legorreta.

Recent Awards and Honors

Tomasz Ahrends and Kevin Gonzales receive Tri-Institutional Breakout Awards

June 2, 2022

Tomasz Ahrends, from Daniel Mucida’s lab, and Kevin Gonzales, from Elaine Fuchs’s lab, are recognized for their respective postdoctoral work.

Leslie B. Vosshall

Leslie B. Vosshall named a member of the American Philosophical Society

June 1, 2022

Vosshall is honored for her investigation of how sensory stimuli are perceived and processed.

More awards and honors

Rockefeller in the News

The Washington Post

“What we are looking for is potentially very rare genetic variants with a very big impact on the individual,” said András Spaan, a clinical microbiologist and fellow at the Rockefeller University in New York who is spearheading a search for genetic material responsible for coronavirus resistance.    

Science News

Michel Nussenzweig and colleagues examined what happens to the immune response after a third dose of vaccine, focusing especially on very long-lived immune cells called memory B cells. Those memory cells still made new antibodies when they got a third look at the vaccine.

Nature

Erich Jarvis says he wants the Human Pangenome Project to achieve a better representation of human genetic diversity. “I’m a person of colour. I grew up as an African American. I grew up as an under-represented minority in the sciences,” he says. “My diversity is not represented. So I have a personal motivation and a societal one to make sure that this pangenome really represents populations.”      

Seek magazine

Rockefeller’s flagship publication is interested not just in scientific results, but in the people, ideas, and conversations that ignite discovery. The latest issue explores how stem cells help our bodies form, develop, and heal—and how they’re powering a new surge in science. Also: Do flies ever get lonely? And much more.


From this issue

 


Subscribe to Rockefeller Science News

Did you know Rockefeller has a monthly science newsletter? Subscribe now to stay on top of the latest discoveries, news updates, and science highlights from Rockefeller’s laboratories and researchers.